Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Newly Approved Agents in the Management of Urothelial Bladder Carcinoma

published 5 months ago by Dr Neil Love

Featuring an interview with Dr Matthew D Galsky on the following topics: Newly approved agents in the management of advanced urothelial bladder carcinoma (UBC) (0:00) Case: A woman in her early 50s with metastatic UBC and an FGFR3 alteration attains a complete response to erdafitinib (25:28) Case: A man in his late 70s with advanced UBC receives enfortumab vedotin after disease progression on pembrolizumab (28:28) CME information and select publications

more episodes from Research To Practice | Oncology Videos